CAPRELSA® REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa®) in Current Clinical Practice

Clinical trial NCT02109250 · COMPLETED

Trial details

NCT number: NCT02109250
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Medullary Thyroid Cancer

Start date: 2014-04-01
Primary completion: 2015-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.